Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -5.43% and Operating profit at -19.95% over the last 5 years
2
With a fall in Net Sales of -18.61%, the company declared Very Negative results in Sep 25
3
With ROE of 8.45%, it has a expensive valuation with a 3.45 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
33.33%
0%
33.33%
6 Months
51.82%
0%
51.82%
1 Year
41.54%
0%
41.54%
2 Years
48.61%
0%
48.61%
3 Years
26.27%
0%
26.27%
4 Years
-15.61%
0%
-15.61%
5 Years
10.25%
0%
10.25%
Shanghai Rongtai Health Technology Corp., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-5.43%
EBIT Growth (5y)
-19.95%
EBIT to Interest (avg)
10.67
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.60
Tax Ratio
11.71%
Dividend Payout Ratio
58.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.73%
ROE (avg)
10.39%
Valuation key factors
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
3.45
EV to EBIT
53.44
EV to EBITDA
35.30
EV to Capital Employed
5.20
EV to Sales
4.00
PEG Ratio
NA
Dividend Yield
1.27%
ROCE (Latest)
9.72%
ROE (Latest)
8.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
442.20
424.70
4.12%
Operating Profit (PBDIT) excl Other Income
24.80
11.00
125.45%
Interest
0.50
0.00
Exceptional Items
-3.40
37.40
-109.09%
Consolidate Net Profit
69.20
39.10
76.98%
Operating Profit Margin (Excl OI)
56.10%
-12.10%
6.82%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 4.12% vs 25.69% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 76.98% vs 54.55% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,555.70
1,590.30
-2.18%
Operating Profit (PBDIT) excl Other Income
132.70
208.30
-36.29%
Interest
21.20
6.50
226.15%
Exceptional Items
44.00
-5.70
871.93%
Consolidate Net Profit
150.00
191.80
-21.79%
Operating Profit Margin (Excl OI)
45.60%
93.10%
-4.75%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -2.18% vs -14.07% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -21.79% vs -5.66% in Dec 2024
About Shanghai Rongtai Health Technology Corp., Ltd. 
Shanghai Rongtai Health Technology Corp., Ltd.
Electronics & Appliances
No Details Available.
Company Coordinates 
No Company Details Available






